About Valens Pharma
Edmonton-based Valens Pharma Ltd., is a privately held, late-stage, biopharmaceutical company focused on commercializing drug product candidates in the novel class of energy metabolism agents, referred to as PDK blockers. The Company's technology is focused on metabolic modulation, through the use of dichloroacetate (DCA) and related compounds, which improve energy production by favouring glucose metabolism. In addition to "DCA i.v." the Company has exciting earlier stage compounds intended to target the treatment of cardiovascular disease, and related metabolic conditions (e.g., diabetes). Cardiovascular disease is the "number one" cause of death in North America, and each year in the United States alone, over 650,000 open heart surgeries are conducted.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of Valens Pharma
News about Valens Pharma
Here you will find Valens Pharma Ltd.
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
